EXPERIENCED TEAM

erin-new-photo.jpg
MICHAEL HEKE.jpeg
frank-razavi.jpg
michael-crowley.jpg

The ATVC Team specializes in commercializing regenerative medicine (RM) and advanced therapy products. Learn more about the unique expertise of each member of our interdisciplinary team by clicking on their names.

Dr. Michael Heke

Managing Director & Chief Scientific Officer

Stephen Morse

Director of Marketing

Erin Crowley

Michael Crowley

Chairman, CEO, Co-Founder &

Co-Managing Member

Frank Razavi

Director Commercialization

& Licensing

President, Co-Founder

 & Co-Managing Member

MorseHeadshot-1.jpg

Michael Crowley, J.D. is serial technology and financial industry entrepreneur who is also both a university collaborator with RIT’s College of Engineering Technology and a Research Professor of Innovation & Entrepreneurship; Professor Crowley is also the Co-Founder & Executive Director of the AT Venture Center and the Founder of the US-China Center for Advanced Technology Venture Creation, LLC

ABOUT:

Erin believes that all startup businesses would gain tremendous benefit and cost savings by implementing a flexible and effective quality management system (QMS) from the very start of their business, because their QMS would ultimately support their overall business growth.

ABOUT:

Dr. Michael Heke has more than 20 years experience in stem cell research. He is currently a Senior Research Scientist in the Department of Biology specializing in the study of stem cells.

ABOUT:

Stephen Morse is a serial entrepreneur, foreign correspondent, dot-com founder and global marketing professional who served as Director of Communications for Xerox Services, a $2.2 billion company.

ABOUT:

As the AT Venture Center’s Director of Commercialization & Licensing, Frank oversees the center’s commercialization related transactions and intellectual property (IP) licensing solutions provided to technology firms and advanced technology institutions (universities, research centers, government labs, etc.) housed in Western New York and throughout the US.

ABOUT:

Tom Conley

Director of Laboratory Operations Processing 

Tom-Conley.jpg

Xianling (Ben) Wang Ph.D

Eileen Crowley

Director of Nanotechnologies

Communications

Consultant

xiangliang-wang.jpg
image.png

 Tom Conley is a lab technician with broad experience in biomedical research. As senior technician for Dr. Omar Aljitawi at the University of Rochester he helped develop the Matrix into the remarkable product it is today.

ABOUT:

Eileen D. Crowley is a writer, scriptwriter, media producer & editor, and communications campaign consultant. Since 1975, she has provided her skills in public relations, employee relations, and media production to corporations and non-profit organizations. She has been honored to serve as a consultant to ATVC, Sanatela, and Regenerelle since the companies’ earliest days.

ABOUT:

WILISDLFIJSODIFSODFN

ABOUT:

As the AT Venture Center’s Director of Nanotechnologies, Xianliang (Ben) Wang oversees the center’s technology for evaluation, verification and Technology-Driven Market Intelligence (TDMI) and Technology Scouting (TS). Ben also conducts comprehensive review regarding technology readiness levels (TRL) and provides project management. Ben also performs technology analysis and due diligence according to market information and end-user requirements and provides the roadmap for the Center’s related transactions.

ABOUT:

Ph.D Weimin Liu Valenti

Scientific Advisor

image000001.jpg

Neil Williamson

Biomedical Engineering Communications Intern

IMG_6479.jpeg

  A third year biomedical engineering student at RIT has become a part of the ATVC team in the last year to work on the translation between visual media and technical knowlegde. His background in lab studies and biology has allowed for a fluid transition into creating content for our company in a variety of capacities.

ABOUT:

WILISDLFIJSODIFSODFN

ABOUT:

Weimin has had a variety of positions that has given her a unique composition of technical and leadership capabilities. As a scientific advisor Weimin is utilizing her specialization to suggest research directives to take.

ABOUT:

WILISDLFIJSODIFSODFN

ABOUT:

DEALS

More than 500 licensing deals successfully completed

CAPITAL RAISING

With experience of raising more than $2.2 Billion

LAUNCH

20+ Advanced Technology companies launched and commercialized

Consulting

Advised numerous Fortune 500 companies and hundreds of technology and manufacturing companies